Endogenous Interleukin 6 Conveys Resistance to cis-Diamminedichloroplatinum-Mediated Apoptosis of the K562 Human Leukemic Cell Line
- 15 June 1999
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 249 (2) , 269-278
- https://doi.org/10.1006/excr.1999.4442
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Interleukin-6 in Biology and MedicinePublished by Elsevier ,1993
- AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.Proceedings of the National Academy of Sciences, 1990
- Analysis of Events Associated With Cell Cycle Arrest at G2 Phase and Cell Death Induced by CisplatinJNCI Journal of the National Cancer Institute, 1990
- A possible autocrine role for interleukin-6 in two lymphoma cell linesBlood, 1989
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.Proceedings of the National Academy of Sciences, 1987
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986
- CisplatinAnnals of Internal Medicine, 1984
- Cell Death: The Significance of ApoptosisPublished by Elsevier ,1980
- The Mechanism of Action of Antitumor Platinum CompoundsProgress in Nucleic Acid Research and Molecular Biology, 1979